Advisors Asset Management’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$200K Buy
3,015
+933
+45% +$79K ﹤0.01% 1167
2026
Q1
$207K Buy
2,082
+426
+26% +$55.6K ﹤0.01% 1139
2025
Q4
$201K Buy
+1,656
New +$208K ﹤0.01% 1126

Other funds holding TMDX

Advisors Asset Management's TMDX Position: Q2 2026 in Review

Advisors Asset Management increased its Transmedics (TMDX) stake by 45% in Q2 2026, buying an estimated $79K and bringing the position to 3,015 shares worth $200K. The position accounts for ﹤0.01% of the portfolio, ranked #1167.

Advisors Asset Management first reported a position in TMDX in Q4 2025 and has held it in 3 quarters since. The position peaked at $207K in Q1 2026. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Advisors Asset Management held 3,015 shares of Transmedics worth $200K as of Q2 2026.
  • Advisors Asset Management bought 933 Transmedics shares in Q2 2026, an estimated $79K.
  • Transmedics made up ﹤0.01% of Advisors Asset Management's portfolio in Q2 2026, its #1167 holding.
  • Advisors Asset Management first reported a position in Transmedics in Q4 2025 and has held it in 3 quarters since.
  • Advisors Asset Management's Transmedics position peaked at $207K in Q1 2026.
  • 375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Advisors Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.